Fergal C Kelleher
Overview
Explore the profile of Fergal C Kelleher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabu D, Kroes J, Gilham C, Fleming A, Kelleher F
Curr Probl Cancer
. 2021 Apr;
45(6):100736.
PMID: 33894989
Basal cell carcinomas occur in up to 39% of Caucasian men and 28% of women. Rarely it can present a management dilemma in patients with neglected locally advanced disease of...
2.
Hamilton J, Alexander M, Kelleher F
Clin Sarcoma Res
. 2020 Dec;
10(1):25.
PMID: 33292592
Background: Encephalopathy is an established side effect of the chemotherapeutic agent, ifosfamide, occurring in 10-30% of cases. The EEG commonly shows non-specific features of encephalopathy, and rarely shows frontal intermittent...
3.
Callaghan G, Kelleher F, Ridgway P, Crowther S, Alakkari A, Ryan B
Eur J Case Rep Intern Med
. 2019 Feb;
5(3):000749.
PMID: 30756014
Introduction: Malignant melanoma of the gastrointestinal tract is usually a metastasis from a cutaneous source. Primary gastric melanoma is an extremely rare clinical entity, with few reported cases worldwide. It...
4.
Kelleher F, Kroes J, Lewin J
Carcinogenesis
. 2018 Dec;
40(4):493-499.
PMID: 30508038
It has been historically uncertain if extra centrosomes are a cause or consequence of tumorigenesis. Experiments have recently established that overexpression of polo-like kinase 4 (PLK4) promotes centrosome amplification with...
5.
OSullivan D, Dowling P, Joyce H, Mcauley E, McCann A, Henry M, et al.
Br J Cancer
. 2017 Sep;
117(9):1326-1335.
PMID: 28881357
Background: Discovery and validation of new antibody tractable targets is critical for the development of new antibody therapeutics to address unmet needs in oncology. Methods: A highly invasive clonal variant...
6.
OSullivan H, Kelleher F, Lavelle M, McGovern B, Murphy J, Swan N, et al.
Pancreas
. 2017 Aug;
46(8):e67-e69.
PMID: 28796141
No abstract available.
7.
Kelleher F, Callaghan G, Gallagher C, OSullivan H
World J Gastroenterol
. 2017 May;
23(17):3022-3029.
PMID: 28533659
Colonic polyps may arise from BRAF inhibitor treatment of melanoma, possibly due to paradoxical activation of the mitogen-activated protein (MAP)-kinase pathway. In an alternative evidence based scenario, tubular colonic adenomas...
8.
Kelleher F, OSullivan H
J Adolesc Young Adult Oncol
. 2017 Mar;
6(3):396-405.
PMID: 28263668
Macrophages appear to have a fundamental role in the pathogenesis of osteosarcoma. These highly diverse plastic cells are subdivided into classical or inflammatory macrophages known as M1 and alternative macrophages,...
9.
Kelleher F, OSullivan H
Oncotarget
. 2016 Apr;
7(27):42792-42804.
PMID: 27074562
FOXM1 is a pro-proliferative transcription factor that promotes cell cycle progression at the G1-S, and G2-M transitions. It is activated by phosphorylation usually mediated by successive cyclin - cyclin dependent...
10.